格劳科斯眼科

最新新闻

• 评级变动
  Truist Financial Maintains Glaukos(GKOS.US) With Buy Rating, Announces Target Price $180
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• 评级变动
  BTIG Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $164
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• 评级变动
  BTIG Maintains Glaukos(GKOS.US) With Buy Rating, Maintains Target Price $162
  \u5e02\u573a\u8d44\u8baf · 2026/7/6
• Stifel Maintains Glaukos(GKOS.US) With Buy Rating, Maintains Target Price $175
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• 评级变动
  Piper Sandler Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $195
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  H.C. Wainwright Initiates Glaukos(GKOS.US) With Buy Rating, Announces Target Price $168
  \u5e02\u573a\u8d44\u8baf · 2026/7/6
• 评级变动
  Piper Sandler Maintains Glaukos(GKOS.US) With Buy Rating, Maintains Target Price $165
  \u5e02\u573a\u8d44\u8baf · 2026/7/1
• 评级变动
  Citi Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $225
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Stifel Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $175
  \u5e02\u573a\u8d44\u8baf · 2026/7/17
• 评级变动
  Analysts Conflicted on These Healthcare Names: Alumis Inc. (ALMS), Glaukos (GKOS) and Regeneron (REGN)
  TipRanks · 2026/7/1
• 评级变动
  J.P. Morgan Maintains Glaukos(GKOS.US) With Buy Rating, Announces Target Price $200
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  Citi Maintains Glaukos(GKOS.US) With Buy Rating, Maintains Target Price $225
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Citi Maintains Glaukos(GKOS.US) With Buy Rating, Maintains Target Price $175
  \u5e02\u573a\u8d44\u8baf · 2026/7/8
• 评级变动
  A Quick Look at Today's Ratings for Glaukos(GKOS.US), With a Forecast Between $172 to $215
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  A Quick Look at Today's Ratings for Glaukos(GKOS.US), With a Forecast Between $178 to $215
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  Needham Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $150
  \u5e02\u573a\u8d44\u8baf · 2026/6/17
• Stifel Maintains Glaukos(GKOS.US) With Buy Rating, Maintains Target Price $190
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• Jefferies Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $210
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• BTIG Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $202
  \u5e02\u573a\u8d44\u8baf · 2026/8/20

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。